ROCHESTER, N.Y.--(BUSINESS WIRE)--

ACM Global Central Lab, the central laboratory that continually defines the customer-service standard with its flexible approach, is pleased to announce that Mark Engelhart has joined the executive management team as chief commercial officer. Engelhart will be responsible for leading ACM Globals business development, proposals and contracts, marketing and sales activities worldwide.

Prior to joining ACM Global, Engelhart was chief commercial officer at Cryoport, Inc. a provider of leading-edge cold chain logistics services. His experience also includes serving in varying sales and marketing management and operations roles at leading pharmaceutical companies, including Bayer and Abbot Laboratories. Engelhart has also held the role of vice president of global sales and marketing at Covance Laboratory, Quest Diagnostics Clinical Trials division and Esoterix Clinical Trials Services.

We are extremely pleased to have Mark join ACM Global, said Angela J. Panzarella, president of ACM Global Central Lab. Mark is a highly accomplished senior executive with deep experience in sales, marketing, strategy, and global commercial operations for central laboratory services and clinical trials support services, and will be a valuable addition to our executive team.

ACM Global will be on hand to discuss the latest trends in clinical research lab testing at PCMG Annual Conference, June 13-15 at the Pine Cliffs Hotel in Portugal and at the 48th Annual DIA Meeting, June 24-28 in Philadelphia.

About ACM Global Central Lab

ACM Global Central Lab offers a flexible approach and a focus on precision to keep clinical research studies on schedule. ACM Globals services extend to more than 60 countries with all tests conducted and managed from central lab facilities with seamless data management providing a single database. The organization performs 14 million tests each year, featuring more than 1,500 individual tests spanning all medical disciplines, including pathology, microbiology, flow cytometry and pharmacogenomics. Combining comprehensive safety, efficacy and pathology testing from a single lab ensures clients receive consistent, analyzable test results with faster and cleaner reporting.

For more information, visit http://www.acmgloballab.com, our Central Labs in Focus blog or call +1 866 405 0400.

See the rest here:
ACM Global Central Laboratory Appoints Mark Engelhart as Chief Commercial Officer